Literature DB >> 19810379

Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.

Kh Sulochana Devi1, Ng Brajachand Singh, H Lokhendro Singh, Y Manihar Singh.   

Abstract

Detection of hepatitis B surface antigen (HBsAg), anti hepatitis C virus (HCV) antibody and anti human immunodeficiency virus (HIV) antibody was carried out in serum samples from 250 injecting drug users (IDUs) from a deaddiction centre, Shalom, in Churachanpur district, Manipur during the period of August-October, 2002. One hundred and forty-nine (59.6%) IDUs were positive for HIV antibody, 226 (90.4%) were positive for anti HCV antibody and 27 (10.8%) were positive for HBsAg. There was coinfection of HIV, hepatitis B virus (HBV) and HCV in 15 (6%) of the IDUs. The coinfection of HBV and HCV was found in 12 cases (4.8%) and coinfection of HIV and HCV was found in 131 cases (52.4%). HIV and HCV were the highest among the coinfection of IDUs. The IDUs were in sexually active age group with a risk of infection to their sexual partner.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19810379

Source DB:  PubMed          Journal:  J Indian Med Assoc        ISSN： 0019-5847


  9 in total

Review 1.  Indian National Association for Study of the Liver (INASL) Guidance for Antiviral Therapy Against HCV Infection: Update 2016.

Authors:  Pankaj Puri; Vivek A Saraswat; Radha K Dhiman; Anil C Anand; Subrat K Acharya; Shivaram P Singh; Yogesh K Chawla; Deepak N Amarapurkar; Ajay Kumar; Anil Arora; Vinod K Dixit; Abraham Koshy; Ajit Sood; Ajay Duseja; Dharmesh Kapoor; Kaushal Madan; Anshu Srivastava; Ashish Kumar; Manav Wadhawan; Amit Goel; Abhai Verma; Gaurav Pandey; Rohan Malik; Swastik Agrawal
Journal:  J Clin Exp Hepatol       Date:  2016-07-02

2.  The natural history of injecting drug use: a 25-year longitudinal study of a cohort of injecting drug users in inner city Dublin.

Authors:  F D O'Kelly; C M O'Kelly
Journal:  Ir J Med Sci       Date:  2012-03-20       Impact factor: 1.568

Review 3.  Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy.

Authors:  Mindie H Nguyen; Grace Wong; Edward Gane; Jia-Horng Kao; Geoffrey Dusheiko
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

4.  A cross-sectional study of liver function tests in HIV-infected persons in Western India.

Authors:  Sunny Pathania; Navjyot Kaur; Sandeep Kumar; V K Sashindran; Pankaj Puri
Journal:  Med J Armed Forces India       Date:  2017-01-07

5.  High prevalence of hepatitis delta virus among patients with chronic hepatitis B virus infection and HIV-1 in an intermediate hepatitis B virus endemic region.

Authors:  Shanmugam Saravanan; Vidya Madhavan; Vijayakumar Velu; Kailapuri G Murugavel; Greer Waldrop; Sunil S Solomon; Pachamuthu Balakrishnan; Nagalingeswaran Kumarasamy; Davey M Smith; Kenneth H Mayer; Suniti Solomon; Sadras P Thyagarajan
Journal:  J Int Assoc Provid AIDS Care       Date:  2013-05-30

6.  HIV/HBV Co-Infections: Epidemiology, Natural History, and Treatment: A Review Article.

Authors:  R Ranjbar; A Davari; M Izadi; N Jonaidi; S M Alavian
Journal:  Iran Red Crescent Med J       Date:  2011-12-01       Impact factor: 0.611

7.  High burden of hepatitis C & HIV co-infection among people who inject drugs in Manipur, Northeast India.

Authors:  Michelle Kermode; Amenla Nuken; Gajendra Kumar Medhi; Brogen Singh Akoijam; H Umesh Sharma; Jagadish Mahanta
Journal:  Indian J Med Res       Date:  2016-03       Impact factor: 2.375

Review 8.  Liver involvement in human immunodeficiency virus infection.

Authors:  Pankaj Puri; Sandeep Kumar
Journal:  Indian J Gastroenterol       Date:  2016-06-03

9.  Co-infection of human immunodeficiency virus, hepatitis C and hepatitis B virus among injection drug users in Drop in centers.

Authors:  Abbasali Javadi; Behrooz Ataei; Nazila Kassaian; Zary Nokhodian; Majid Yaran
Journal:  J Res Med Sci       Date:  2014-03       Impact factor: 1.852
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.